Jean Claude Brouet

High-Dose Therapy and Autologous Blood Stem-Cell Transplantation Compared With Conventional Treatment in Myeloma Patients Aged 55 to 65 Years: Long-Term Results of a Randomized Control Trial From the Group Myelome-Autogreffe

Jean‐Paul Fermand, Sandrine Katsahian, Marine Diviné et al. · Journal of Clinical Oncology · 2005 · 401 citations · Full text

Medicine, Hematology, Oncology +17

Are Complicated Forms of Celiac Disease Cryptic T-Cell Lymphomas?

Franck Carbonnel, Laurence Grollet-Bioul, Jean Claude Brouet et al. · Blood · 1998 · 148 citations

Medicine, Immunology, Pathology +14

Phase II trial of arsenic trioxide and alpha interferon in patients with relapsed/refractory adult T-cell leukemia/lymphoma

Olivier Hermine, Hervé Dombret, Joël Poupon et al. · The Hematology Journal · 2004 · 125 citations

Medicine, Hematology, Oncology +11

Synthesis of abnormal immunoglobulins in lymphoplasmacytic disorders with visceral light chain deposition

Jean Louis Preud'homme, L Morel-Marogér, Jean Claude Brouet et al. · The American Journal of Medicine · 1980 · 112 citations

Life Sciences, Immunology, Pathology +13

Renal Lesions in Multiple Myeloma: Their Relationship to Associated Protein Abnormalities

Gary S. Hill, L Morel-Marogér, Jean-Philippe Wry et al. · American Journal of Kidney Diseases · 1983 · 95 citations

Medicine, Nephrology, Pathology +16